Trading Stocks, Not the Market

The market seems in pause mode, but it is still tough to flip bearish. For now, I'll continue to focus on trying to trade some breakout names to the upside and just keep an eye on the overall market. I haven't found any advantage to trading the large indices rather than individual names currently. 

Biotech has been nothing short of hot, and Alnylam Pharma (ALNY) looks to be breaking out higher today. This one has been in a strong channel for months now, but it also seems to be pushing out of a nice rounding pattern with good volume today. Pair the bullish MACD crossover with a strong CCI, and I'm looking for a push to $65 as the Bollinger bands expand here....226 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.

Read the full story and get access to the Real Money Pro trading floor.

There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.

Already a Subscriber? Please login.

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.